Comparison the perioperative effects of the intramuscular Dexmedetomidine and Midazolam Premedication for Suspension Laryngoscopy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-12002042

Enrollment

Unknown

Registered

2012-03-26

Start date

2012-04-02

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vocal cord polyp

Interventions

D:intramuscular Dexmedetomidine before induction of anesthesia

M:intramuscular Midazolam before induction of anesthesia

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: The patient who are ASAI and ready for undergoing laryngeal microsurgery. At the same time the age of the patient must between 18 to 60 and the BMI must be less than 30.

Exclusion criteria

Exclusion criteria: The patient complicated with 1. Difficult intubation; 2. Hypertension; 3. Heart and lung disease; 4. Consumption of alpha 2 adrenergic agonist or Antagonist recently, will be excluded.

Design outcomes

Primary

Measure	Time frame
Narcotrend Index;Heart Rate;Blood Pressure;	—

Secondary

Measure	Time frame
Target concentration of propofol;Target concentration of remifentanil;OAA/S;SOMC;	—

Countries

China

Contacts

Public ContactXiangcai Ruan

xc_ruan@hotmail.com+86 13760710099

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026